Matches in Wikidata for { <http://www.wikidata.org/entity/Q73492029> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q73492029 description "article scientifique publié en 2000" @default.
- Q73492029 description "artikull shkencor i botuar më 01 janar 2000" @default.
- Q73492029 description "artículu científicu espublizáu en xineru de 2000" @default.
- Q73492029 description "im Jahr 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73492029 description "scientific article published on 01 January 2000" @default.
- Q73492029 description "wetenschappelijk artikel" @default.
- Q73492029 description "wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch" @default.
- Q73492029 description "наукова стаття, опублікована в січні 2000" @default.
- Q73492029 name "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 name "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 name "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 type Item @default.
- Q73492029 label "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 label "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 label "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 prefLabel "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 prefLabel "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 prefLabel "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 P1433 Q73492029-8F473733-7238-4A0F-96E4-A26C453D1F8E @default.
- Q73492029 P1476 Q73492029-AED31239-C292-4CE6-B76E-06406B4CEA58 @default.
- Q73492029 P2093 Q73492029-545875D0-FA33-4E37-84C1-63522B79D5CE @default.
- Q73492029 P2093 Q73492029-73C926F7-8E42-461B-83AC-A43DF08604CA @default.
- Q73492029 P2093 Q73492029-7AEBC448-894A-4046-B542-35432639E327 @default.
- Q73492029 P2093 Q73492029-A3E724B6-3184-4E48-8BDE-313FE0E63248 @default.
- Q73492029 P2093 Q73492029-C0CC7732-71AE-4EE8-AAA6-55DA7A6A664E @default.
- Q73492029 P2093 Q73492029-C5760E86-2523-47DA-91A8-6155AF05B7BE @default.
- Q73492029 P304 Q73492029-2D0D5EF2-DC9C-43DC-AEAF-D1185D94FED4 @default.
- Q73492029 P31 Q73492029-F050BF8B-9771-4937-92C5-7B2D2EB4CA51 @default.
- Q73492029 P433 Q73492029-04F67470-46BE-48C2-AC78-E3B9EC02D381 @default.
- Q73492029 P478 Q73492029-A33BE8A8-64F5-45A7-BC13-1FB5246F86AB @default.
- Q73492029 P577 Q73492029-CFD6EDAD-089A-40B9-B24B-C0DF17E77634 @default.
- Q73492029 P698 Q73492029-8E7B1490-73B0-472D-985F-41FE29711960 @default.
- Q73492029 P921 Q73492029-9C621240-A370-44EE-886F-F42B63272C9A @default.
- Q73492029 P698 10694294 @default.
- Q73492029 P1433 Q18620944 @default.
- Q73492029 P1476 "High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels" @default.
- Q73492029 P2093 "Anegg B" @default.
- Q73492029 P2093 "Göttfried I" @default.
- Q73492029 P2093 "Rieger A" @default.
- Q73492029 P2093 "Seeber A" @default.
- Q73492029 P2093 "Stingl G" @default.
- Q73492029 P2093 "Volc-Platzer B" @default.
- Q73492029 P304 "29-35" @default.
- Q73492029 P31 Q13442814 @default.
- Q73492029 P433 "1" @default.
- Q73492029 P478 "10" @default.
- Q73492029 P577 "2000-01-01T00:00:00Z" @default.
- Q73492029 P698 "10694294" @default.
- Q73492029 P921 Q681160 @default.